Kidney cancer, though less common in women, often presents diagnostic challenges due to its resemblance to common female ...

Since Buckingham Palace confirmed King Charles had cancer in 2024, medical professionals around the globe have tried to ...

The technology, known as histotripsy, offers a non-invasive treatment capable of breaking down liver cancer tissue without ...

Appendix cancer is rising rapidly among millennials, with experts linking lifestyle, environmental and genetic factors. Learn ...

Though extremely rare, cancers of the appendix are being diagnosed at higher rates in Gen X and millennials compared with ...

The NHS is set to become the only health system in Europe to use ground-breaking histotripsy technology, which removes the ...

In a world where preventive health is gaining increasing importance, incorporating regular kidney check-ups alongside heart ...

HistoSonics, Inc., the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today ...

The urology ultrasound devices market is projected to grow at a CAGR of 6%, driven by the rising prevalence of urological ...

After 3 years of follow-up, treatment failure had occurred in 5.6% of patients treated with focused ablation and 7.9% of the prostatectomy groups. The difference did not achieve statistical ...

1Department of Urology, Stanford School of Medicine, Stanford, California. 1Department of Urology, Stanford School of Medicine, Stanford, California. 2Department of Epidemiology and Population Health, ...

Active surveillance is the least invasive treatment option for managing kidney cancer. Urologic oncologist Nirmish Singla, M.D., M.Sc., of Johns Hopkins’ kidney cancer program, explains how it works.